...
首页> 外文期刊>Heart and vessels: An international journal >Autoperipheral blood mononuclear cell transplantation improved giant ulcers due to chronic arteriosclerosis obliterans.
【24h】

Autoperipheral blood mononuclear cell transplantation improved giant ulcers due to chronic arteriosclerosis obliterans.

机译:由于慢性闭塞性动脉硬化,外周血单个核细胞移植改善了巨大的溃疡。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

We report the case of a 74-year-old man with Fontaine stage IV chronic arteriosclerosis obliterans who had been suffering from inveterate giant skin ulcers on the dorsum and heel of the right foot. As conventional medical treatments had not improved these ulcers and surgical treatment was considered unfeasible, amputation of the right lower limb below the knee appeared to represent the only option. The patient was admitted to Tottori University Hospital to attempt a new angiogenic therapy using auto-mononuclear cell transplantation to avoid amputation. On admission, neither right ankle blood pressure nor transcutaneous partial pressure of oxygen at the right toe were detectable. The patient had a history of multiple cerebral infarctions, and collection of mononuclear cells from bone marrow was considered too difficult, so collection of peripheral blood mononuclear cells was selected. Transcutaneous partial pressure of oxygen and skin temperature in the treated limb started to improve from 2 weeks afterimplantation. Ulcer size was recognizably reduced by 1 month after treatment. Partial auto-skin implantation on the right heel was performed 2 months after treatment, and the giant skin ulcer was finally completely covered. No adverse effects were noted during follow-up lasting 1 year. These results suggest that peripheral blood mononuclear cell implantation may offer a suitable alternative rescue therapy for patients with critical limb ischemia whose general condition is not good.
机译:我们报告了一个患有Fontaine IV期慢性闭塞性动脉硬化症的74岁男性患者的病例,该患者患有右足背和足跟的巨大的皮肤溃疡。由于传统的药物治疗方法并不能改善这些溃疡,并且手术治疗被认为是不可行的,因此膝下右下肢的截肢似乎是唯一的选择。该患者入鸟取大学医院尝试使用自体单核细胞移植避免截肢的新血管生成疗法。入院时,未检测到右脚踝血压或右脚趾的经皮氧气分压。该患者有多发性脑梗塞病史,从骨髓中收集单核细胞被认为太困难,因此选择了外周血单核细胞。从植入后2周开始,经治疗的肢体中的经皮氧气分压和皮肤温度开始改善。治疗后1个月,溃疡大小明显减少。治疗后2个月,在右脚后跟进行部分自体皮肤植入,最终彻底覆盖了巨大的皮肤溃疡。持续1年的随访期间未发现不良反应。这些结果表明,外周血单核细胞植入可能为一般状况不佳的重症肢体缺血患者提供合适的替代挽救疗法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号